Related Experiment Video
Updated: Aug 8, 2026
09:33
Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Drug-associated disease: cytochrome P450 interactions
1Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, 7-153 WDH, 308 Harvard Street SE, Minneapolis, MN 55455, USA. hmann@umn.edu
Critical Care Clinics
|May 9, 2006
Summary
Critically ill patients often experience drug interactions due to multiple medications and organ failure. Understanding drug interaction mechanisms, especially involving the cytochrome P450 system, is key to preventing adverse effects.
Area of Science:
- Pharmacology
- Critical Care Medicine
- Drug Metabolism
Background:
- Critically ill patients are older, have organ failure, and take multiple drugs, increasing susceptibility to adverse drug events.
- Drug interactions are a frequent adverse effect in this population.
- Predicting drug interactions is possible by understanding their underlying mechanisms.
Purpose of the Study:
- To identify common medications used in critically ill patients.
- To highlight potential drug interactions associated with these medications.
- To emphasize the role of the cytochrome P450 enzyme system in drug interactions.
Main Methods:
- Review of commonly prescribed medications in intensive care units.
- Analysis of known drug interaction pathways.
- Focus on interactions mediated by cytochrome P450 enzymes.
Main Results:
- Identification of frequently used drugs in critical care.
- Cataloging of significant drug-drug interactions.
- Explanation of cytochrome P450's role in these interactions.
Conclusions:
- Awareness of common drug interactions is crucial for critically ill patients.
- Understanding cytochrome P450 pathways aids in predicting and preventing adverse drug events.
- This knowledge supports safer medication management in intensive care settings.
Related Concept Videos
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...